The monkey pox or monkeypox continues to grow in the world and many countries have confirmed more than one hundred cases. only in Perumore than 500 cases were announced in 15 regions.
Faced with this growth, many began to ask about the vaccine, which exists but is not widely available to protect everyone from this disease.
According to data from Africa, the smallpox vaccine is at least 85% effective in prevention.
In 2019, the United States FDA approved a smallpox and monkeypox vaccine known as Jynneos, Imvamune, or Imvanex. It is manufactured by Bavarian Nordic, and is approved for adults over the age of 18 who may be at risk of becoming infected.
What does the vaccine contain?
It is made from the virus vaccinia, which is linked to the viruses that cause smallpox and monkeypox, but is different. It has a modified form of that virus that does not cause disease and cannot reproduce in human cells.
Do you have side effects?
The vaccine is given in two doses four weeks apart. Side effects such as pain, redness, headache, fatigue, and swelling or itching at the injection site are reported.
The monkeypox vaccine is manufactured by the Danish company Bavarian Nordic. This company also makes vaccines against rabies and tick-borne encephalitis, and a couple of years ago they developed an Ebola vaccine, which was licensed to Janssen.
Which countries already have their vaccines?
Bavarian Nordic signed a contract with the United States for 119 million dollars to supply the vaccine with additional options. Which would be a total of 13 million vaccines for Americans.
In addition, the company announced another deal with an undisclosed European country for vaccines.
Spain, France and Great Britain are some of the countries that are already inoculating their most vulnerable population.
Peru looks for its doses
Through a press conference of the Council of Ministers, George Lopez, Minister of Health, assured that Peru will buy the vaccine against said disease and that said acquisition will be jointly with more South American countries.
It is known that the purchase will be made through the Pan American Health Organization (PAHO). “Yesterday the expert committee met regarding the acquisition of the vaccine. They have determined that the vaccine will be acquired. Let’s hope they deliver the doses to us in due course.” commented.